Ticker: GKOS

Company Overview: Glaukos Corporation (NYSE: GKOS), based in Aliso Viejo, California, is an ophthalmic pharmaceutical and medical technology company focused on developing therapies for glaucoma, corneal disorders, and retinal diseases. Recent Developments: - Acquired Mobius Therapeutics for $12....

Glaukos Corporation (NYSE: GKOS) is an ophthalmic pharmaceutical and medical technology company focused on innovating treatments for glaucoma and corneal disorders. Despite steady improvements in revenue, the company continues to grapple with high operating costs and significant accumulated losse...